CD34 and chronic myelogenous leukemia, BCR-ABL1 positive: The CML LSCs reside in the CD34+/CD38− fraction as the normal ones [63], and a good CD marker useful to distinguish them is expected to be preferentially expressed in one of the two populations, the leukemic or the normal one.